Convergence of Communications and Medical Systems: The Opportunities and the Challenges

This post was written by Judy Harris, Amy Mushahwar and Areta Kupchyk.

The Federal Communications Commission (FCC) just announced that, as part of its implementation of the recently released National Broadband Plan and the Plan's recommendation to use the power of broadband to improve healthcare, the FCC and the Food and Drug Administration (FDA) are going to be holding a public meeting on July 26 and 27, 2010, to discuss regulatory issues arising from the convergence of wireless technology and healthcare devices.  The meeting is formally entitled: "Enabling the Convergence of Communications and Medical Systems: Ways to Update Regulatory and Information Processes."  The purpose of this meeting is, among other things, to discuss ways to promote investment and innovation in health technology by streamlining government processes.
 
To help develop an agenda for this important meeting, the FDA and the FCC are seeking input from, among others, the medical and device manufacturing industries, practitioners, and other stakeholders and users of medical technology on a number of questions regarding regulatory challenges and safety of patients and other users of medical devices that include radio elements and of systems that can be tied into broadband communications networks.  The information gathered will be used to enhance coordination between the FDA and the FCC for healthcare devices and applications and clarify the respective areas of expertise and jurisdiction between the agencies.  The solicitation of this information is intended to simplify and expedite the introduction of new medical technologies and devices.  

To this end, the FCC and the FDA have released a list of specific topics on which they are seeking input. Those topics are included in the Public Notice.

Commenters, however, are not limited to addressing the specific topics set forth, but rather should feel free to raise any issue of interest or concern.  The details of the two-day meeting at the end of July will be shaped by the comments received.  After those comments are reviewed, a final agenda for the meeting will be posted on the Internet.  

Comments are due June 25, so time is of the essence

Finally, the meeting will be open to the public and there will be an opportunity for interested parties to make oral presentations during any of the open comment sessions.  Preregistration to attend the meeting is desirable and required should you wish to speak.  The registration deadline is July 19th.

Please contact Judy Harris, Amy Mushahwar or Areta Kupchyk if you would like further information regarding these issues.

FCC Proposes Tougher Rules on Telemarketing

This post was written by Robert H. Jackson.

The Federal Communications Commission (“FCC”) has proposed changes to its Telephone Consumer Protection Act (“TCPA”) rules that would conform to the Federal Trade Commission’s Telemarketing Sales Rule (“TSR”). The primary change in the regulations would affect the sending of prerecorded messages (a/k/a “robocalls”) by barring them even to existing customers without first obtaining prior written consent. At first blush, this seems routine, but because of differences in the FCC’s and FTC’s statutory jurisdiction, there are complicated implementation issues that could trap unsuspecting companies. Other key issues for the health care industry is whether the FCC should create an exemption for prerecorded messages that are subject to Health Insurance Portability and Accountability Act (“HIPAA”) and, if so, how such exemption should be implemented. For more information about these changes, please read our client alert written by Robert Jackson.

Implanted Neuromuscular Stimulator Notice Comments Dates Released

This post was written by Judith L. Harris and Amy S. Mushahwar.

As previously reported, the Federal Communications Commission ("FCC") proposes to allot spectrum and adopt service and technical rules for new implanted medical devices that would expand the use of functional electric stimulation to restore sensation, mobility and function to paralyzed limbs and organs. As an update to this report, yesterday the FCC published the Notice of Proposed Rulemaking ("Notice") regarding implanted neuromuscular simulators in the Federal Register and released the comments dates. Comments are due August 11, 2009 and replies are due on September 10, 2009.

This additional allotment for electronic stimulation technologies could be used to develop devices for the medical treatment for millions of people living with brain and spinal cord injuries and neuromuscular disorders, such as multiple sclerosis, polio, cerebral palsy and Lou Gehrig’s Disease. These implanted neuromuscular micro stimulators would function as wireless broadband medical micro-power networks (“MMNs”) within a patient. By eliminating the wires now used to interconnect multiple implanted neuromuscular micro stimulators and the external power source for the implants, MMNs would greatly reduce the risk of infection and increase patient mobility and system reliability.

The Notice seeks comment on the feasibility of allowing up to 20 MHz of spectrum in the 413–457 MHz band to be used under the Medical Device Radiocommunication Service (“MedRadio Service”) in Part 95 of the Commission’s rules, and seeks comment on the allocation of four specific segments for this purpose: 413–419 MHz, 426 432 MHz, 438–444 MHz, and 451–457 MHz. The Notice also seeks comment on the prospective service and technical rules that would govern MMN operations, such as transmitter power, emission bandwidth, duty cycle, contention protocols, and other operating specifications that generally comport with the framework of the existing MedRadio Service. The Notice proposes to limit MMN operations to use only by persons for diagnostic and therapeutic purposes, and only to the extent provided under the direction of authorized health care professionals.

FCC Allocates More Spectrum to Wireless Medical Devices and Proposes Even More Spectrum for Implanted Neuromuscular Stimulators

This post was written by Judith L. Harris and Amy S. Mushahwar.

The Federal Communications Commission (“FCC”) recently released an Order allocating 2 MHz of new spectrum for advanced wireless implanted devices, which may enable the certification of new devices by the FCC’s Office of Engineering and Technology.

The FCC also seeks comment on a proposal to allocate up to 20 MHz of spectrum for implanted neuromuscular micro stimulators. This additional allotment for electronic stimulation technologies could be used to develop devices for the medical treatment for millions of people living with brain and spinal cord injuries and neuromuscular disorders.

Parties interested in registering new devices under the FCC’s Order or in commenting on the additional spectrum allotment for electronic stimulation technologies are encouraged to contact Judith L. Harris or Amy S. Mushahwar.

For additional information, please see Reed Smith's full alert.